Although there is a clear correlation between the emergence of tamoxifen resistance in breast cancer and the association of BCAR3 with p130Cas/BCAR1, the available data on the functional meaning of this interaction appear controversial [50]. The gene discussed is BCAR1; the disease is breast carcinoma.